News
Een kijkje achter de schermen bij de toekenningspartijen
De Nederlandse LSH-sector blinkt uit door de intensieve samenwerking met internationale topwetenschappers en de dynamische band tussen het bedrijfsleven en de academische wereld.
From lab to market: Irati's startup journey
“Even though it’s risky, I trust in my technology,” says Irati Beltrán Hernández, who is setting up a science startup with Sebas Pronk
Join the Dutch Lounge at Nordic Life Science Days 2024
The Nordic Life Science Days (NLSDays) is the premiere venue for doing business with Nordic life science companies and where new international connections are made in the Nordics.
XS-Innovations is hiring: Senior Design Engineer
Globally, 2.5 million patients rely on kidney dialysis machines three times a week as their lifeline. The high blood flow needed for these three-hour sessions is achieved through a surgically created connection between an artery and a vein in the arm.
ExCulture secures funding from the Dutch Industrial Biotech Seed Fund (managed by Capricorn Partners) and TTT Medtech
Leiden, 12th July 2024 – ExCulture B.V., a biotechnology startup focused on the development of an animal-free heparin substitute via fermentation, is proud to share that it has closed its latest funding round with Capricorn Partners and T
Call for startups: pitch opportunity at Investors Forum
Young companies active in the life sciences industry, pitch your company and/or innovations at the Dutch Life Sciences conference. Increase your visibility, earn PR and connect to collaboration partners and investors.
Impact the world with your mission-driven business initiative and elevate your career in life sciences: join the BioBusiness Masterclass!
As a biotech entrepreneur, you are at the forefront of developing next-generation diagnostics, treatments, sustainable foods, and a range of other biobased products.
FETCH wins Venture Challenge Spring 2024!
The winner of the Venture Challenge was announced today at the Dutch Biotech Event.
UPyTher attracts seed financing to advance the development of its lead product UPT-211 for treatment of peritoneal cancer of colorectal cancer origin.
Eindhoven, The Netherlands, June 10th, 2024, UPyTher announces seed financing from Essential Investments, Brabant Development Agency (BOM) and TTT Medtech.
The consortium led by ParaMedir awarded with more than €1.8 Million in European Funding by Just Transition Fund (JTF) to advance Healthcare through innovative biomonitoring solutions.
Groningen, 14th June, 2024 – ParaMedir proudly announces the award of approximately €1.8 million in European funding from the Just Transition Fund (JTF).